Nevertheless, we conclude that the combination of p53 and BRCA1 deficiency can drive CIN in a context-dependent manner, where low levels of BRCA1 activity such as observed in PB1 remain protective. This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.